These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 33883901)
1. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway. Fan S; Yan S; Yang Y; Shang J; Hao M Onco Targets Ther; 2021; 14():2463-2473. PubMed ID: 33883901 [TBL] [Abstract][Full Text] [Related]
2. Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3'-kinase/protein kinase B/mammalian target of rapamycin pathway. Zhang MH; Liu J Bioengineered; 2022 Apr; 13(4):10047-10060. PubMed ID: 35412944 [TBL] [Abstract][Full Text] [Related]
3. PIK3CA mutation confers resistance to chemotherapy in triple-negative breast cancer by inhibiting apoptosis and activating the PI3K/AKT/mTOR signaling pathway. Hu H; Zhu J; Zhong Y; Geng R; Ji Y; Guan Q; Hong C; Wei Y; Min N; Qi A; Zhang Y; Li X Ann Transl Med; 2021 Mar; 9(5):410. PubMed ID: 33842631 [TBL] [Abstract][Full Text] [Related]
4. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway. Chen X; Zhang W; Xu X World J Surg Oncol; 2021 Aug; 19(1):232. PubMed ID: 34362378 [TBL] [Abstract][Full Text] [Related]
5. ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling. DA X; Ge H; Shi J; Zhu C; Wang G; Fang Y; Xu J Oncol Res; 2024; 32(7):1209-1219. PubMed ID: 38948021 [TBL] [Abstract][Full Text] [Related]
6. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway. Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381 [TBL] [Abstract][Full Text] [Related]
7. Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells. Zhao Z; Ma J; Mao Y; Dong L; Li S; Zhang Y Med Sci Monit; 2018 Sep; 24():6851-6860. PubMed ID: 30260937 [TBL] [Abstract][Full Text] [Related]
8. Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy. Zhang S; Cui T; Duan Y; Zhang H; Wang B; Chen H; Ni J; Shen Y; Xiao-Ai Lv Clin Breast Cancer; 2022 Feb; 22(2):89-97. PubMed ID: 34535390 [TBL] [Abstract][Full Text] [Related]
9. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma. Li B; Zhu J; Meng L Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476 [TBL] [Abstract][Full Text] [Related]
10. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer Liao H; Zhang L; Lu S; Li W; Dong W Front Genet; 2022; 13():848926. PubMed ID: 35812733 [No Abstract] [Full Text] [Related]
11. Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways. Liu L; Yan J; Cao Y; Yan Y; Shen X; Yu B; Tao L; Wang S Oncol Lett; 2021 Jan; 21(1):70. PubMed ID: 33365081 [TBL] [Abstract][Full Text] [Related]
12. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling. Cheng W; Liu D; Guo M; Li H; Wang Q Drug Dev Res; 2022 Aug; 83(5):1138-1151. PubMed ID: 35426453 [TBL] [Abstract][Full Text] [Related]
13. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway. Wu C; Qiu S; Liu P; Ge Y; Gao X J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway. Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-6071 Suppresses Glioblastoma Progression Through the Inhibition of PI3K/AKT/mTOR Pathway by Binding to ULBP2. Zhou Y; An H; Wu G Onco Targets Ther; 2020; 13():9429-9441. PubMed ID: 33061429 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A. Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639 [TBL] [Abstract][Full Text] [Related]
17. α2A-Adrenergic Receptor Inhibits the Progression of Cervical Cancer Through Blocking PI3K/AKT/mTOR Pathway. Wang W; Guo X; Dan H Onco Targets Ther; 2020; 13():10535-10546. PubMed ID: 33116632 [TBL] [Abstract][Full Text] [Related]
18. UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA-MB-231 cells. Yue X; Li M; Chen D; Xu Z; Sun S Exp Ther Med; 2018 Nov; 16(5):3921-3928. PubMed ID: 30344670 [TBL] [Abstract][Full Text] [Related]
19. Chamomile Essential Oil: Chemical Constituents and Antitumor Activity in MDA-MB-231 Cells through PI3K/Akt/mTOR Signaling Pathway. An Z; Feng X; Sun M; Wang Y; Wang H; Gong Y Chem Biodivers; 2023 Apr; 20(4):e202200523. PubMed ID: 36941224 [TBL] [Abstract][Full Text] [Related]
20. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells. Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]